Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors (Englisch)
- Neue Suche nach: Lockhart, A. Craig
- Neue Suche nach: Sundaram, Shankar
- Neue Suche nach: Sarantopoulos, John
- Neue Suche nach: Mita, Monica M.
- Neue Suche nach: Wang-Gillam, Andrea
- Neue Suche nach: Moseley, Jennifer L.
- Neue Suche nach: Barber, Stephanie L.
- Neue Suche nach: Lane, Alex R.
- Neue Suche nach: Wack, Claudine
- Neue Suche nach: Kassalow, Laurent
- Neue Suche nach: Dedieu, Jean-François
- Neue Suche nach: Mita, Alain C.
- Neue Suche nach: Lockhart, A. Craig
- Neue Suche nach: Sundaram, Shankar
- Neue Suche nach: Sarantopoulos, John
- Neue Suche nach: Mita, Monica M.
- Neue Suche nach: Wang-Gillam, Andrea
- Neue Suche nach: Moseley, Jennifer L.
- Neue Suche nach: Barber, Stephanie L.
- Neue Suche nach: Lane, Alex R.
- Neue Suche nach: Wack, Claudine
- Neue Suche nach: Kassalow, Laurent
- Neue Suche nach: Dedieu, Jean-François
- Neue Suche nach: Mita, Alain C.
In:
Investigational New Drugs
;
32
, 6
; 1236-1245
;
2014
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
-
Beteiligte:Lockhart, A. Craig ( Autor:in ) / Sundaram, Shankar ( Autor:in ) / Sarantopoulos, John ( Autor:in ) / Mita, Monica M. ( Autor:in ) / Wang-Gillam, Andrea ( Autor:in ) / Moseley, Jennifer L. ( Autor:in ) / Barber, Stephanie L. ( Autor:in ) / Lane, Alex R. ( Autor:in ) / Wack, Claudine ( Autor:in ) / Kassalow, Laurent ( Autor:in )
-
Erschienen in:Investigational New Drugs ; 32, 6 ; 1236-1245
-
Verlag:
- Neue Suche nach: Springer US
- Neue Suche nach: Springer Science + Business Media B.V
-
Erscheinungsort:Dordrecht [u.a.]
-
Erscheinungsdatum:2014
-
ISSN:
-
ZDBID:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
- Neue Suche nach: 44.40 / 44.40$jPharmazie$jPharmazeutika
- Weitere Informationen zu Basisklassifikation
-
Schlagwörter:
-
Klassifikation:
BKL: 44.40 Pharmazie, Pharmazeutika / 44.40$jPharmazie$jPharmazeutika -
Datenquelle:
Inhaltsverzeichnis – Band 32, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1053
-
Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cellsKuete, Victor / Sandjo, Louis P. / Djeussi, Doriane E. / Zeino, Maen / Kwamou, Guy M. N. / Ngadjui, Bonaventure / Efferth, Thomas et al. | 2014
- 1063
-
Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5’ RNA genome end methodologyIsraelsson, S. / Sävneby, A. / Ekström, J-O. / Jonsson, N. / Edman, K. / Lindberg, A. M. et al. | 2014
- 1071
-
Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicitiesWaterhouse, Dawn N. / Sutherland, Brent W. / Santos, Nancy Dos / Masin, Dana / Osooly, Maryam / Strutt, Dita / Ostlund, Christina / Anantha, Malathi / Harasym, Natashia / Manisali, Irina et al. | 2014
- 1083
-
“Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183”Marchetti, Serena / Pluim, Dick / Beijnen, Jos H. / Mazzanti, Roberto / van Tellingen, Olaf / Schellens, Jan H. M. et al. | 2014
- 1096
-
Ibrutinib ($ Imbruvica^{TM} $) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cellsGrabinski, Nicole / Ewald, Florian et al. | 2014
- 1105
-
CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse modelsKim, Sun-Hee / Margalit, Ofer / Katoh, Hiroshi / Wang, Dingzhi / Wu, Hong / Xia, Dianren / Holla, Vijaykumar R. / Yang, Peiying / DuBois, Raymond N. et al. | 2014
- 1113
-
Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cellsRussell, E. G. / O’Sullivan, E. C. / Miller, C. M. / Stanicka, J. / McCarthy, F. O. / Cotter, T. G. et al. | 2014
- 1123
-
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancerValtorta, Silvia / Nicolini, Gabriella / Tripodi, Farida / Meregalli, Cristina / Cavaletti, Guido / Avezza, Federica / Crippa, Luca / Bertoli, Gloria / Sanvito, Francesca / Fusi, Paola et al. | 2014
- 1134
-
In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CAKong, Dexin / Yamori, Takao / Yamazaki, Kanami / Dan, Shingo et al. | 2014
- 1144
-
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitorsEwald, Florian / Nörz, Dominik / Grottke, Astrid / Hofmann, Bianca T. / Nashan, Björn / Jücker, Manfred et al. | 2014
- 1155
-
AD-O53.2—a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2LPieczykolan, Jerzy S. / Kubiński, Konrad / Masłyk, Maciej / Pawlak, Sebastian D. / Pieczykolan, Anna / Rózga, Piotr K. / Szymanik, Michał / Gałązka, Marlena / Teska-Kamińska, Małgorzata / Żerek, Bartłomiej et al. | 2014
- 1167
-
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistanceSero, Valeria / Tavanti, Elisa / Vella, Serena / Hattinger, Claudia Maria / Fanelli, Marilù / Michelacci, Francesca / Versteeg, Rogier / Valsasina, Barbara / Gudeman, Beth / Picci, Piero et al. | 2014
- 1181
-
Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: Phase 1 dose-escalation studyFalchook, Gerald / Kurzrock, Razelle / Gouw, Launce / Hong, David / McGregor, Kimberly A. / Zhou, Xiaofei / Shi, Hongliang / Fingert, Howard / Sharma, Sunil et al. | 2014
- 1188
-
Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin/docetaxel or carboplatin/paclitaxel in patients with advanced solid tumorsBahleda, Rastislav / Sessa, Cristiana / Del Conte, Gianluca / Gianni, Luca / Capri, Giuseppe / Varga, Andrea / Oprea, Corina / Daglish, Byzance / Hospitel, Marie / Soria, Jean-Charles et al. | 2014
- 1197
-
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neckBowles, Daniel W. / Senzer, Neil / Hausman, Diana / Peterson, Scott / Vo, Alex / Walker, Luke / Cohen, Roger B. / Jimeno, Antonio et al. | 2014
- 1204
-
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumorsHong, D. S. / Henary, H. / Falchook, G. S. / Naing, A. / Fu, S. / Moulder, S. / Wheler, J. J. / Tsimberidou, A. / Durand, J. B. / Khan, R. et al. | 2014
- 1213
-
Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patientsGopal, Ajay K. / Tarantolo, Stefano R. / Bellam, Naresh / Green, Damian J. / Griffin, Melissa / Feldman, Tatyana / Mato, Anthony R. / Eisenfeld, Amy J. / Stromatt, Scott C. / Goy, Andre et al. | 2014
- 1226
-
A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumorsChu, Quincy S. / Sangha, Randeep / Hotte, Sebastien J. / Sergenson, Gwen / Schnell, David / Chand, Vikram K. / Hirte, Hal W. et al. | 2014
- 1236
-
Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumorsLockhart, A. Craig / Sundaram, Shankar / Sarantopoulos, John / Mita, Monica M. / Wang-Gillam, Andrea / Moseley, Jennifer L. / Barber, Stephanie L. / Lane, Alex R. / Wack, Claudine / Kassalow, Laurent et al. | 2014
- 1246
-
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinomaTannir, Nizar M. / Forero-Torres, Andres / Ramchandren, Radhakrishnan / Pal, Sumanta K. / Ansell, Stephen M. / Infante, Jeffrey R. / de Vos, Sven / Hamlin, Paul A. / Kim, Stella K. / Whiting, Nancy C. et al. | 2014
- 1258
-
An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancerPili, Roberto / Carducci, Michael / Brown, Peter / Hurwitz, Herbert et al. | 2014
- 1269
-
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinBrana, Irene / Ocana, Alberto / Chen, Eric X. / Razak, Albiruni R. A. / Haines, Christine / Lee, Carol / Douglas, Sarah / Wang, Lisa / Siu, Lillian L. / Tannock, Ian F. et al. | 2014
- 1278
-
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)Ruzsa, A. / Sen, M. / Evans, M. / Lee, L. W. / Hideghety, K. / Rottey, S. / Klimak, P. / Holeckova, P. / Fayette, J. / Csoszi, T. et al. | 2014
- 1285
-
A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancerZhao, Meng / Pan, Xueliang / Layman, Rachel / Lustberg, Maryam B. / Mrozek, Ewa / Macrae, Erin R. / Wesolowski, Robert / Carothers, Sarah / Puhalla, Shannon / Shapiro, Charles L. et al. | 2014
- 1295
-
The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicityTastekin, Didem / Tambas, Makbule / Kilic, Kemal / Erturk, Kayhan / Arslan, Deniz et al. | 2014
- 1301
-
Human uridine phosphorylase-1 inhibitors: a new approach to ameliorate 5-fluorouracil-induced intestinal mucositisRenck, Daiana / Santos, André A. / Machado, Pablo / Petersen, Guilherme O. / Lopes, Tiago G. / Santos, Diógenes S. / Campos, Maria M. / Basso, Luiz A. et al. | 2014
- 1308
-
Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumorsCarbonnaux, Mélodie / Molin, Yann / Souquet, Pierre-Jean / Tantin, Arnaud / Lombard-Bohas, Catherine / Walter, Thomas et al. | 2014
- 1311
-
Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitorsWoo, Hyun Sun / Ahn, Hee Kyung / Lee, Ha Yeon / Park, Inkeun / Kim, Young Saing / Hong, Junshik / Sym, Sun Jin / Park, Jinny / Lee, Jae Hoon / Shin, Dong Bok et al. | 2014
- 1316
-
Contributions from emerging transcriptomics technologies and computational strategies for drug discoveryKadioglu, Onat / Efferth, Thomas et al. | 2014